Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03702907 · ClinicalTrials.gov registry record
DC Longitudinal Study on Aging and Specimen Bank
A clinical trial of Alzheimer Disease and Aging, sponsored by Georgetown University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT03702907: Recruiting study of Alzheimer Disease and Aging, sponsored by Georgetown University.
NCT03702907 is a study of Alzheimer Disease and Aging that is actively recruiting participants, run by Georgetown University. The registered enrollment target is 1,000 participants, below the 2,747-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03702907, a study of Alzheimer Disease and Aging, is actively recruiting participants, sponsored by Georgetown University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Georgetown University Memory Disorders Program, part of the Department of Neurology, is conducting pilot studies of the feasibility of various diagnostic tests for Alzheimer's disease, mild cognitive impairment and other neurodegenerative diseases. Further, this study is assessing longitudinal changes in biological, lifestyle, and cognitive assessment collection. The primary goal of this study is to examine the feasibility of biochemical assays, genetic testing, and cognitive and lifestyle assessments in the ante-mortem diagnosis of Alzheimer's disease, mild cognitive impairment and other neurodegenerative diseases. This research involves genetic and cognitive status testing but the findings will not be shared with research subjects. This will be accomplished ex vivo using blood, and/or cerebrospinal fluid (CSF) specimens from patients with a diagnosis of probable Alzheimer's disease, mild cognitive impairment, or other neurodegenerative diseases and from normal controls.
Primary Outcome
Clinical Dementia Rating
Conditions Studied
Study Locations (1)
District of Columbia
- Georgetown University Memory Disorders Program - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2007-01-01 |
| Est. Completion | 2027-01 |
What NCT03702907 shows while recruiting
NCT03702907 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 2,747-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (64% lower).
The record links to 5 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03702907 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT03702907 about?
NCT03702907 is a clinical study titled "DC Longitudinal Study on Aging and Specimen Bank". The Georgetown University Memory Disorders Program, part of the Department of Neurology, is conducting pilot studies of the feasibility of various diagnostic tests for Alzheimer's disease, mild cognitive impairment and other neurodegenerative diseases. Further, this study is assessing longitudinal c...
What is the current status of trial NCT03702907?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2007-01-01. Estimated completion is 2027-01.
What conditions does trial NCT03702907 study?
This clinical trial studies the following conditions: Alzheimer Disease, Aging, Mild Cognitive Impairment, Dementia, Aging Disorder.
Who is sponsoring clinical trial NCT03702907?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03702907 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03702907's enrollment target sits among peer trials
1,000 30th of 306 higher than 274 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)
RECRUITING · Phase 3
-
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
RECRUITING · Phase 4
-
Systemic and Central Inflammation in AD
RECRUITING · Phase 2
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
RECRUITING · Phase 1
-
Cognitive Neurology Unit Clinical Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI